You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has launched Recipharm Analytical Solutions, a stand-alone service to support pharmaceutical companies with their Quality Control (QC) and analytical requirements. Recipharm Analytical Solutions, which launches at CPhI Worldwide, November 5 – 7, Frankfurt, Germany, offers analyticalAlready a subscriber Login You have read all your free articles, to continue…
Recipharm and LIDDS have signed an exclusive collaboration agreement regarding scale-up of the production process and commercial manufacture of Liproca Depot, LIDDS patented targeted treatment for prostate cancer. The agreement will be an important component for the upcoming Phase IIb study which isAlready a subscriber Login You have read all…
Recipharm has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand. The investment will see the opening of a 500 square metre purpose-built facility in Already a subscriber Login You have…
Recipharm has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new 370 m2 area is fully cGMP compliant and is equipped with technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm AnalyticalAlready a subscriber Login You…
